首页> 外文期刊>Allergy, Asthma & Immunology Research >Improvement of Eosinophilic Otitis Media by Optimized Asthma Treatment
【24h】

Improvement of Eosinophilic Otitis Media by Optimized Asthma Treatment

机译:通过优化哮喘治疗改善嗜酸性中耳炎

获取原文
           

摘要

Eosinophilic otitis media (EOM) shows a very high rate of association with asthma, and intractable otitis media involves marked eosinophil infiltration into the middle ear. The middle ear space is connected to the nasopharynx by the Eustachian tube, and it is considered a part of the upper respiratory tract. Allergic rhinitis and asthma often coexist as chronic inflammatory diseases of the upper and lower airways, respectively, and have an impact on each other. In fact, inhaled corticosteroids reduce seasonal eosinophilia systemically in the circulation and locally in the nasal mucosa, as well as attenuate seasonal nasal symptoms. We report a case of EOM associated with adult-onset asthma that improved following optimal asthma therapy after changing the treatment from inhaled fluticasone propionate (FP) (200 μg b.i.d .) to a combination of FP/salmeterol (250/50 μg b.i.d .). This result supports the hypothesis that EOM and asthma are closely linked, presenting as different manifestations of a similar disease syndrome.
机译:嗜酸性中耳炎(EOM)与哮喘的发病率非常高,顽固性中耳炎涉及嗜酸性粒细胞明显渗入中耳。中耳腔通过咽鼓管连接到鼻咽,被认为是上呼吸道的一部分。变应性鼻炎和哮喘通常分别作为上,下呼吸道的慢性炎性疾病并存,并且相互影响。实际上,吸入皮质类固醇可在循环系统和鼻黏膜局部减轻季节性嗜酸性粒细胞增多,并减轻季节性鼻症状。我们报道了一例与成人发作性哮喘有关的EOM病例,将最佳治疗方法从吸入丙酸氟替卡松(FP)(200μgbid。)改为FP /沙美特罗(250/50μgbid)组合后,改善了。 。该结果支持以下假设:EOM和哮喘密切相关,表现为相似疾病综合征的不同表现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号